These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25635351)
21. Antitrypanosomal structure-activity-relationship study of synthetic cynaropicrin derivatives. Usuki T; Sato M; Hara S; Yoshimoto Y; Kondo R; Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M Bioorg Med Chem Lett; 2014 Feb; 24(3):794-8. PubMed ID: 24433861 [TBL] [Abstract][Full Text] [Related]
22. Trypanosoma brucei: effects of methoprene and other isoprenoid compounds on procyclic and bloodstream forms in vitro and in mice. Harmon MA; Scott TC; Li Y; Boehm MF; Phillips MA; Mangelsdorf DJ Exp Parasitol; 1997 Nov; 87(3):229-36. PubMed ID: 9371088 [TBL] [Abstract][Full Text] [Related]
23. Eugenia uniflora and Syzygium samarangense extracts exhibit anti-trypanosomal activity: Evidence from in-silico molecular modelling, in vitro, and in vivo studies. Abdelfattah MAO; Ibrahim MA; Abdullahi HL; Aminu R; Saad SB; Krstin S; Wink M; Sobeh M Biomed Pharmacother; 2021 Jun; 138():111508. PubMed ID: 33756157 [TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents. Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888 [TBL] [Abstract][Full Text] [Related]
25. Identification of selective tubulin inhibitors as potential anti-trypanosomal agents. Lama R; Sandhu R; Zhong B; Li B; Su B Bioorg Med Chem Lett; 2012 Sep; 22(17):5508-16. PubMed ID: 22850214 [TBL] [Abstract][Full Text] [Related]
26. In vitro Anti-Trypanosomal Activities of Indanone-Based Chalcones. Beteck RM; Legoabe LJ; Isaacs M; Hoppe HC Drug Res (Stuttg); 2019 Jun; 69(6):337-341. PubMed ID: 30452077 [TBL] [Abstract][Full Text] [Related]
27. Selective and potent in vitro antitrypanosomal activities of ten microbial metabolites. Otoguro K; Ishiyama A; Namatame M; Nishihara A; Furusawa T; Masuma R; Shiomi K; Takahashi Y; Yamada H; Omura S J Antibiot (Tokyo); 2008 Jun; 61(6):372-8. PubMed ID: 18667785 [TBL] [Abstract][Full Text] [Related]
28. New leads for trypanosomiasis chemotherapy. Lancet; 1978 Dec; 2(8101):1190. PubMed ID: 82152 [No Abstract] [Full Text] [Related]
29. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei. Loiseau PM; Wolf JG; Gayral P Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630 [TBL] [Abstract][Full Text] [Related]
30. In vitro antitrypanosomal activity of the cyclodepsipeptides, cardinalisamides A-C, from the insect pathogenic fungus Cordyceps cardinalis NBRC 103832. Umeyama A; Takahashi K; Grudniewska A; Shimizu M; Hayashi S; Kato M; Okamoto Y; Suenaga M; Ban S; Kumada T; Ishiyama A; Iwatsuki M; Otoguro K; Omura S; Hashimoto T J Antibiot (Tokyo); 2014 Feb; 67(2):163-6. PubMed ID: 24084682 [TBL] [Abstract][Full Text] [Related]
31. Trypanocidal drugs: mechanisms, resistance and new targets. Wilkinson SR; Kelly JM Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838 [TBL] [Abstract][Full Text] [Related]
32. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents. Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi. Velásquez AM; Francisco AI; Kohatsu AA; Silva FA; Rodrigues DF; Teixeira RG; Chiari BG; de Almeida MG; Isaac VL; Vargas MD; Cicarelli RM Bioorg Med Chem Lett; 2014 Apr; 24(7):1707-10. PubMed ID: 24630563 [TBL] [Abstract][Full Text] [Related]
34. In vitro antitrypanosomal activity of five low-MW antibiotics. Ishiyama A; Otoguro K; Iwatsuki M; Namatame M; Nishihara-Tsukashima A; Takahashi Y; Onodera H; Yamada H; Omura S J Antibiot (Tokyo); 2012 Feb; 65(2):113-4. PubMed ID: 22167160 [No Abstract] [Full Text] [Related]
35. Lead optimization of selective tubulin inhibitors as anti-trypanosomal agents. Zhao A; Li Y; Orahoske CM; Schnur B; Sabbagh A; Zhang W; Li B; Su B Bioorg Med Chem; 2019 Apr; 27(8):1517-1528. PubMed ID: 30833159 [TBL] [Abstract][Full Text] [Related]
36. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis. Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377 [TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo antiprotozoal activities of bispolides and their derivatives. Otoguro K; Iwatsuki M; Ishiyama A; Namatame M; Nishihara-Tsukashima A; Sato S; Hatsu M; Iinuma H; Shibahara S; Nimura S; Kondo S; Yamada H; Omura S J Antibiot (Tokyo); 2010 May; 63(5):275-7. PubMed ID: 20379214 [No Abstract] [Full Text] [Related]
38. (+)-7-Deaza-5'-noraristeromycin as an anti-trypanosomal agent. Seley KL; Schneller SW; Rattendi D; Bacchi CJ J Med Chem; 1997 Feb; 40(4):622-4. PubMed ID: 9046353 [TBL] [Abstract][Full Text] [Related]
39. Total Synthesis and Determination of the Absolute Configuration of Naturally Occurring Mangromicin A, with Potent Antitrypanosomal Activity. Takada H; Yamada T; Hirose T; Ishihara T; Nakashima T; Takahashi YK; O Mura S; Sunazuka T Org Lett; 2017 Jan; 19(1):230-233. PubMed ID: 27936806 [TBL] [Abstract][Full Text] [Related]
40. Mangromicins A and B: structure and antitrypanosomal activity of two new cyclopentadecane compounds from Lechevalieria aerocolonigenes K10-0216. Nakashima T; Iwatsuki M; Ochiai J; Kamiya Y; Nagai K; Matsumoto A; Ishiyama A; Otoguro K; Shiomi K; Takahashi Y; Ōmura S J Antibiot (Tokyo); 2014 Mar; 67(3):253-60. PubMed ID: 24326338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]